ATE7690T1 - Zwischenprodukte zur herstellung von thienamycin und verfahren zur herstellung von zwischenprodukten. - Google Patents

Zwischenprodukte zur herstellung von thienamycin und verfahren zur herstellung von zwischenprodukten.

Info

Publication number
ATE7690T1
ATE7690T1 AT80104296T AT80104296T ATE7690T1 AT E7690 T1 ATE7690 T1 AT E7690T1 AT 80104296 T AT80104296 T AT 80104296T AT 80104296 T AT80104296 T AT 80104296T AT E7690 T1 ATE7690 T1 AT E7690T1
Authority
AT
Austria
Prior art keywords
manufacture
intermediate products
thienamycin
methods
chem
Prior art date
Application number
AT80104296T
Other languages
English (en)
Inventor
Burton G. Christensen
Ronald W. Ratcliffe
Thomas N. Salzmann
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE7690T1 publication Critical patent/ATE7690T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/04Preparation by forming the ring or condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT80104296T 1979-07-23 1980-07-22 Zwischenprodukte zur herstellung von thienamycin und verfahren zur herstellung von zwischenprodukten. ATE7690T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5984479A 1979-07-23 1979-07-23
EP80104296A EP0026816B1 (de) 1979-07-23 1980-07-22 Zwischenprodukte zur Herstellung von Thienamycin und Verfahren zur Herstellung von Zwischenprodukten

Publications (1)

Publication Number Publication Date
ATE7690T1 true ATE7690T1 (de) 1984-06-15

Family

ID=22025641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80104296T ATE7690T1 (de) 1979-07-23 1980-07-22 Zwischenprodukte zur herstellung von thienamycin und verfahren zur herstellung von zwischenprodukten.

Country Status (9)

Country Link
EP (1) EP0026816B1 (de)
JP (3) JPS5620571A (de)
AT (1) ATE7690T1 (de)
DE (1) DE3068029D1 (de)
DK (1) DK314380A (de)
ES (1) ES8105709A1 (de)
GR (1) GR69337B (de)
IE (1) IE50070B1 (de)
PT (1) PT71553B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3276316D1 (en) * 1981-08-27 1987-06-19 Fujisawa Pharmaceutical Co Carbapenam compound and processes for the preparation thereof
HU184495B (en) * 1981-12-30 1984-08-28 Richter Gedeon Vegyeszet Process for preparing new azetidinone-acetic acids
HU184496B (en) * 1981-12-30 1984-08-28 Richter Gedeon Vegyeszet Process for producing new azetidinon-acetic acid derivatives
HU185081B (en) * 1981-12-30 1984-11-28 Richter Gedeon Vegyeszet Process for preparing azetidinone-acetic acid derivatives
JPS58167566A (ja) * 1982-03-27 1983-10-03 Kanegafuchi Chem Ind Co Ltd (4r)−(2−ヒドロキシエチル)−2−アゼチジノン及びその誘導体の製法
HU190404B (en) * 1982-07-30 1986-09-29 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing amino-lactone-carboxylic acid
HU187424B (en) * 1982-11-05 1986-01-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing new azetidinyl-acetic acids
CA1220215A (en) * 1983-03-07 1987-04-07 Yasutsugu Ueda Carbapenem intermediates
HU188913B (en) * 1983-06-23 1986-05-28 Richter Gedeon Vegyeszeti Gyar,Rt,Hu Process for producing new azetidinyl-acetic acid esters
NZ214691A (en) * 1984-12-27 1988-08-30 Sumitomo Pharma The preparation of carbapenem derivatives and beta-lactam intermediates
EP0567949B1 (de) * 1992-04-28 2001-02-21 Tanabe Seiyaku Co., Ltd. Verfahrenzur Abspaltung von Silylschutzgruppen aus geschützten HO-Gruppen
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174316A (en) * 1978-08-14 1979-11-13 Merck & Co., Inc. 4-Iodomethylazetidin-2-one

Also Published As

Publication number Publication date
EP0026816A1 (de) 1981-04-15
PT71553A (en) 1980-08-01
DK314380A (da) 1981-01-24
ES493599A0 (es) 1981-06-16
JPS5620571A (en) 1981-02-26
JPH0422908B2 (de) 1992-04-20
IE801503L (en) 1981-01-23
GR69337B (de) 1982-05-17
JPH047740B2 (de) 1992-02-12
JPH0223558B2 (de) 1990-05-24
IE50070B1 (en) 1986-02-05
JPS6479147A (en) 1989-03-24
PT71553B (en) 1981-12-14
JPH02160763A (ja) 1990-06-20
ES8105709A1 (es) 1981-06-16
DE3068029D1 (en) 1984-07-05
EP0026816B1 (de) 1984-05-30

Similar Documents

Publication Publication Date Title
ATE415394T1 (de) Zwischeprodukte zur herstellung von retroviralen protease-hemmern
DE3580803D1 (de) Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2-azetidinonen.
HUT63419A (en) Process for producing mercaptoacetamide derivatives of pyrrolo-, pyrido- and oxazinobenzazepine having encephalinase- and angiotensin-converting enzyme-inhibiting activity
ATE145891T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür
HUT64310A (en) Compositions containing substituted aryl-halogenalkyl-pyrazol derivatives having herbicidal activity and process for producing said compounds
ATE7690T1 (de) Zwischenprodukte zur herstellung von thienamycin und verfahren zur herstellung von zwischenprodukten.
DE69311260D1 (de) Verfahren zur Herstellung von (E)-Alkoximino- oder Hydroxyiminoacetamidverbindungen und Zwischenprodukte
ATE155469T1 (de) Verfahren zur herstellung von cephemderivaten
ATE201025T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenprodukte in diesem verfahren
ATE10372T1 (de) Synisomer von cephalosporinverbindungen und verfahren zu ihrer herstellung.
DE69233249D1 (de) Verfahren zur Herstellung von einem 3-Cephem-4-Carbonsäurederivat
DE69428845D1 (de) Verfahren zur Herstellung von Sende-Empfängern
DE3885818D1 (de) Trinatriumsalz des 2,4,6-Trimercapto-s-triazin-nonahydrats und Verfahren zur Herstellung.
DE69416018D1 (de) Verfahren zur Herstellung von Alkoxyiminoacetamid-Verbindungen
ATE36318T1 (de) Verfahren zur herstellung von azetidinderivaten und zwischenprodukte.
DE69113323D1 (de) Verfahren zur Herstellung von alpha-Hydroxycarbonsäure amiden.
DE59010896D1 (de) Verfahren zur Herstellung von 7-(3-Amino- sowie 3-Aminomethyl-1-pyrrolidinyl)-3-chinolon-carbonsäuren sowie -naphthyridoncarbonsäuren
DE59308496D1 (de) Verbessertes Verfahren zur Herstellung von R/S-gamma-Liponsäure oder R/S-alpha-Liponsäure
DE69032153D1 (de) Verfahren zur Herstellung von Butantetracarboxylat
ATE224393T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenverbindungen in diesem verfahren
ATE3042T1 (de) Verfahren zur herstellung von 6aminopenicillans[ure-1,1-dioxid und seiner salze.
DE69014747D1 (de) Verfahren zur Herstellung von Kaliumtitanarsenat-Einkristallen.
ATE78817T1 (de) Verfahren zur herstellung von substituierten isothiazolonen.
ATE124053T1 (de) Verfahren zur herstellung von tripeptiden.
ATE21898T1 (de) Salz von 3-thienylmalonsaeure und verfahren zur herstellung von 3-thienylmalonsaeure.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee